PIFELTRO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Doravirine.
| Product ID | 50090-6268_f78eba3a-fa42-4d5d-a965-2ffd975eb86e | 
| NDC | 50090-6268 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | PIFELTRO | 
| Generic Name | Doravirine | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2018-07-20 | 
| Marketing Category | NDA / | 
| Application Number | NDA210806 | 
| Labeler Name | A-S Medication Solutions | 
| Substance Name | DORAVIRINE | 
| Active Ingredient Strength | 100 mg/1 | 
| Pharm Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-12-13 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0006-3069 | PIFELTRO | doravirine | 
| 50090-6237 | PIFELTRO | doravirine | 
| 50090-6268 | PIFELTRO | doravirine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  PIFELTRO  87107184  5807242 Live/Registered | Merck Sharp & Dohme Corp. 2016-07-18 |